Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Passiflorine vs Valeriana in Generalized Anxiety Disorder
NCT01178632Phase 3Unknown
- Sponsor
- Millet Roux
- Start
- Oct 2010
- Primary completion
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of passiflora in generalized anxiety disorder (GAD), sponsored by Millet Roux. Status: unknown.
02
Drugs
passiflora
03
Conditions
generalized anxiety disorder (GAD)
Beyond the preview
Go deeper on NCT01178632.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01178632.